Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Mark Deneau"'
Autor:
Christopher L. Bowlus, Lionel Arrivé, Annika Bergquist, Mark Deneau, Lisa Forman, Sumera I. Ilyas, Keri E. Lunsford, Mercedes Martinez, Gonzalo Sapisochin, Rachna Shroff, James H. Tabibian, David N. Assis
Publikováno v:
Hepatology. 77:E176-E177
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa81498e4a0803aabbb7c9eb5466d337
https://doi.org/10.1097/hep.0000000000000305
https://doi.org/10.1097/hep.0000000000000305
Autor:
Lisa M. Forman, Gonzalo Sapisochin, David N. Assis, Lionel Arrivé, Annika Bergquist, Christopher L. Bowlus, Mark Deneau, Sumera I. Ilyas, Keri E. Lunsford, Mercedes Martinez, Rachna Shroff, James H. Tabibian
Publikováno v:
Hepatology. 77:E97-E98
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e33bb5e89b65ee429ad411ef78730411
https://doi.org/10.1097/hep.0000000000000210
https://doi.org/10.1097/hep.0000000000000210
Autor:
Christopher L. Bowlus, Lionel Arrivé, Annika Bergquist, Mark Deneau, Lisa Forman, Sumera I. Ilyas, Keri E. Lunsford, Mercedes Martinez, Gonzalo Sapisochin, Rachna Shroff, James H. Tabibian, David N. Assis
Publikováno v:
Hepatology (Baltimore, Md.)REFERENCES.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ff96f303ca49721899606704280c280
https://pubmed.ncbi.nlm.nih.gov/36083140
https://pubmed.ncbi.nlm.nih.gov/36083140
Publikováno v:
Journal of Pediatric Surgery. 55:2393-2396
Introduction Enhanced recovery protocols include multimodal perioperative pain control and frequently include use of NSAIDs. There is conflicting evidence that ketorolac use in inflammatory bowel disease (IBD) may precipitate disease flares and posto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8b8a6e8e2eafcc2442281c2e19ea27b
https://doi.org/10.1016/j.jpedsurg.2020.04.001
https://doi.org/10.1016/j.jpedsurg.2020.04.001
Autor:
Kirsten Muri Boberg, Mark Deneau, Christian Rupp, Cyriel Y. Ponsioen, David N. Assis, Bret T. Petersen, Christopher L. Bowlus, Martti Färkkilä, Stefan G. Hubscher, Lars Aabakken, Douglas Thorburn
Publikováno v:
Gastroenterology, 161(6), 1764-1775.e5. W.B. Saunders Ltd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0416d3411ff02d2b3a9c692db636aa4
https://pure.amc.nl/en/publications/defining-primary-sclerosing-cholangitis(e3e9ecf3-9f2c-4cc1-bb41-11a061475185).html
https://pure.amc.nl/en/publications/defining-primary-sclerosing-cholangitis(e3e9ecf3-9f2c-4cc1-bb41-11a061475185).html
Autor:
Bernadette Vitola, Christine K. Lee, Nanda Kerkar, Trevor J. Laborda, Kathleen M. Loomes, Kaija-Leena Kolho, Saeed Mohammed, Madeleine Aumar, Kathleen B. Schwarz, Alexandre Rodrigues Ferreira, Binita M. Kamath, Bart G. P. Koot, Cara L. Mack, Annemarie Broderick, Venna L. Venkat, Katryn N. Furuya, Mary Elizabeth M. Tessier, Girish S. Rao, Mercedes Martinez, Marek Woynarowski, Eleonora Druve Tavares Fagundes, Atsushi Tanaka, Tamir Miloh, Pamela L. Valentino, Laura G. Draijer, Douglas Mogul, Mark Deneau, Vratislav Smolka, Nitika A. Gupta, Amanda Ricciuto, Emily R. Perito, Melissa Zerofsky, Nadia Ovchinsky, Simon Horslen, Maureen M. Jonas, Kyung Mo Kim
Publikováno v:
Hepatology, 74(4), 2047-2057. John Wiley and Sons Ltd
Hepatology
Hepatology
Background and Aims Recurrent primary sclerosing cholangitis (rPSC) following liver transplant (LT) has a negative impact on graft and patient survival; little is known about risk factors for rPSC or disease course in children. Approach and Results W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb28e12c988d05385a8817b747a5af76
https://pure.amc.nl/en/publications/recurrence-of-primary-sclerosing-cholangitis-after-liver-transplant-in-children-an-international-observational-study(aab082d4-579e-4631-b00a-f340eb7d2081).html
https://pure.amc.nl/en/publications/recurrence-of-primary-sclerosing-cholangitis-after-liver-transplant-in-children-an-international-observational-study(aab082d4-579e-4631-b00a-f340eb7d2081).html
Publikováno v:
World Journal of Hepatology
BACKGROUND Congenital dyserythropoietic anemia type 1 (CDA1) is an autosomal recessive disorder of ineffective erythropoiesis, resulting in increased iron storage. CDA1 is usually diagnosed in children and adolescents but can rarely present in the ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2d6cd7453c8ce4cb811b9cedfa92e11
http://europepmc.org/articles/PMC6547294
http://europepmc.org/articles/PMC6547294
Publikováno v:
World Journal of Hepatology
Primary sclerosing cholangitis (PSC) is a rare disease of stricturing and destruction of the biliary tree with a complex genetic and environmental etiology. Most patients have co-occurring inflammatory bowel disease. Children generally present with u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6e3726167efc644595aca5f3f1a5fab
http://europepmc.org/articles/PMC6354124
http://europepmc.org/articles/PMC6354124
Autor:
Pushpa Sathya, Jessica T. Hochberg, Wael El-Matary, Nadia Ovchinsky, Ruchi Singh, Trevor J. Laborda, Douglas Mogul, Matthew DiGuglielmo, Simon Horslen, Emily R. Perito, Maureen M. Jonas, Alexander Miethke, Bart G. P. Koot, Kathleen B. Schwarz, Girish S. Rao, Nitika A. Gupta, Pamela L. Valentino, Cara L. Mack, Mark Deneau, Katryn N. Furuya, Amanda Ricciuto, M. Kyle Jensen, Laura G. Draijer, Nanda Kerkar, Uzma Shah, Achiya Z. Amir, Stephen L. Guthery, Kathleen M. Loomes, Mercedes Martinez, Tamir Miloh, Andréanne Zizzo, Saeed Mohammad, Christine K. Lee, Bernadette Vitola
Publikováno v:
Hepatology
Background and aims Many children with primary sclerosing cholangitis (PSC) receive oral vancomycin therapy (OVT) or ursodeoxycholic acid (UDCA). There is a paucity of data on whether these medications improve outcomes. Approach and results We analyz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acf3b2ebfb947e045c1ea79b0999907f
https://europepmc.org/articles/PMC8557636/
https://europepmc.org/articles/PMC8557636/
Autor:
Matjaz Homan, Binita M. Kamath, Bart G. P. Koot, Mansi Amin, Parvathi Mohan, Amanda Ricciuto, Melissa Zerofsky, Madeleine Aumar, Kathleen B. Schwarz, Laura G. Draijer, Annemarie Broderick, Kaija-Leena Kolho, Stephen L. Guthery, Nanda Kerkar, Saeed Mohammad, Nisreen Soufi, Alexandra Papadopoulou, Eyal Shteyer, Raffaele Iorio, Nadia Ovchinsky, M. Kyle Jensen, Simon Horslen, Ruchi Singh, Maureen M. Jonas, Kyung Mo Kim, Alexander Miethke, Girish S. Rao, Federica Ferrari, Achiya Z. Amir, Cara L. Mack, Douglas Mogul, Matthew DiGuglielmo, Vratislav Smolka, Christine K. Lee, Pushpa Sathya, Katryn N. Furuya, Nitika A. Gupta, Mercedes Martinez, Atsushi Tanaka, Tamir Miloh, Kathleen M. Loomes, Bernadette Vitola, Uzma Shah, Pamela L. Valentino, Andréanne Zizzo, Mark Deneau, Jessica T. Hochberg, Wael El-Matary, Stacy Moroz, Marcus Auth, Emily R. Perito, Trevor J. Laborda, Marek Woynarowski, Eleonora Druve Tavares Fagundes, Alexandre Rodrigues Ferreira, Raghu Varier, Sirish Palle
Publikováno v:
Hepatology (Baltimore, Md.), 73(3), 1074-1087. John Wiley and Sons Ltd
Paediatrics Publications
Paediatrics Publications
Background and Aims: Disease progression in children with primary sclerosing cholangitis (PSC) is variable. Prognostic and risk-stratification tools exist for adult-onset PSC, but not for children. We aimed to create a tool that accounts for the bioc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::637d4623b2b71ae6a097d52eb99df8c2
https://pure.amc.nl/en/publications/the-sclerosing-cholangitis-outcomes-in-pediatrics-scope-index-a-prognostic-tool-for-children(92facea3-8fbb-41d6-adfd-46dfef3c90b7).html
https://pure.amc.nl/en/publications/the-sclerosing-cholangitis-outcomes-in-pediatrics-scope-index-a-prognostic-tool-for-children(92facea3-8fbb-41d6-adfd-46dfef3c90b7).html